National Institute of Health Doutor Ricardo Jorge (INSA) at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

National Institute of Health Doutor Ricardo Jorge (INSA) brings 2 presentations to ESGCT 2026 in Hamburg. Its groups work on CRISPR editing for rare lysosomal diseases. Topics include correcting a recurrent GNPTAB variant in stem cells from patients with mucolipidosis II and using dental pulp stem cells as a platform for editing in MPS IIIC.

OrganizationESGCT 2026 Attendance
Poster
Thu Oct 29
2:00pm–4:00pm
CRISPR/Cas9-mediated gene editing of the recurrent GNPTAB c.3503_3504del variant in Mucolipidosis II iPSCs
Gene Editing
Poster
Thu Oct 29
2:00pm–4:00pm
From Tooth to Therapy: Dental Pulp Stem Cells as a Platform for CRISPR-Mediated Gene Editing in MPS IIIC
Gene Editing

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from National Institute of Health Doutor Ricardo Jorge (INSA)

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction